乳腺癌治疗中组织元素差异导致靶区剂量不均匀性的评估
本研究基于5例乳腺癌患者CT数据集,用蒙特卡洛模拟评估组织化学组成差异对乳腺靶区剂量的影响。结果显示,将脂肪组织误赋为肌肉时,乳腺小叶部分剂量被高估1.25±0.45%;将肌肉组织误赋为脂肪时,脂肪部分剂量被低估1.14±0.51%。Acuros计算显示小叶部分高估0.98±0.06%、脂肪部分低估0.21±0.14%。作者认为差异虽无临床显著性,但有助于理解乳腺放疗剂量分布与均匀性。
要点
- 脂肪组织赋为肌肉时,乳腺小叶部分剂量高估1.25±0.45%。
- 肌肉组织赋为脂肪时,乳腺脂肪部分剂量低估1.14±0.51%。
- Acuros显示小叶部分高估0.98±0.06%,脂肪部分低估0.21±0.14%。
核心结论
- 作者认为,乳腺小叶和结缔脂肪部分剂量沉积差异虽无临床显著性,但有助于提高对乳腺放疗剂量分布和均匀性的认识。
研究设计与样本
- 选取5例乳腺癌患者CT数据集,勾画乳腺为临床靶区CTV,并勾画CTV_lob和CTV_fat分别为整个乳腺的小叶和脂肪部分。
- 患者按容积旋转调强放疗技术计划,在Varian Eclipse治疗计划系统中优化。
- 将CT、结构和计划导入基于蒙特卡洛代码Penelope的PRIMO,运行三种模拟:AdiMus(脂肪和肌肉组织自动赋为乳腺脂肪和小叶部分)、Adi(脂肪赋为整个乳腺)、Mus(肌肉赋为整个乳腺)。
- 保持CT数据集中的特定组织密度一致,评估不同组织赋值下CTV_lob和CTV_fat结构的平均剂量差异,并分析Eclipse中Acuros剂量计算估计的组织组成差异。
主要发现
- 蒙特卡洛模拟中,当脂肪组织赋为肌肉时,乳腺小叶部分剂量被高估1.25±0.45%。
- 蒙特卡洛模拟中,当肌肉组织赋为脂肪时,乳腺脂肪部分剂量被低估1.14±0.51%。
- Acuros显示小叶部分高估0.98±0.06%,脂肪部分低估0.21±0.14%。
- 差异原因在于蒙特卡洛和Acuros两种计算对CT值范围和材料赋值的管理不同,Acuros存在重叠范围,其中两种组织以特定比例同时存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Monte Carlo simulations were run to estimate the dose variations generated by thedifference arising from the chemical composition of the tissues. METHODS: CT datasets of five breast cancer patients were selected. Mammary gland was delineated as clinical target volume CTV, as well as CTV_lob and CTV_fat, being the lobular and fat fractions of the entire mammary gland. Patients were planned for volumetric modulated arc therapy technique, optimized in the Varian Eclipse treatment planning system. CT, structures and plans were imported in PRIMO, based on Monte Carlo code Penelope, to run three simulations: AdiMus, where the adipose and muscle tissues were automatically assigned to fat and lobular fractions of the breast; Adi and Mus, where adipose and muscle, respectively were assigned to the whole mammary gland. The specific tissue density was kept identical from the CT dataset. Differences in mean doses in the CTV_lob and CTV_fat structures were evaluated for the different tissue assignments. Differences generated by the tissue composition and estimated by Acuros dose calculations in Eclipse were also analysed. RESULTS: From Monte Carlo simulations, the dose in the lobular fraction of the breast, when adipose tissue is assigned in place of muscle, is overestimated by 1.25 ± 0.45%; the dose in the fat fraction of the breast with muscle tissue assignment is underestimated by 1.14 ± 0.51%. Acuros showed an overestimation of 0.98 ± 0.06% and an underestimation of 0.21 ± 0.14% in the lobular and fat portions, respectively. Reason of this dissimilarity resides in the fact that the two calculations, Monte Carlo and Acuros, differently manage the range of CT numbers and the material assignments, having Acuros an overlapping range, where two tissues are both present in defined proportions. CONCLUSION: Although not clinically significant, the dose deposition difference in the lobular and connective fat fraction of the breast tissue lead to an improved knowledge of the possible dose distribution and homogeneity in the breast radiation treatment.
引用
- Fogliata A, De Rose F, Stravato A, et al. Evaluation of target dose inhomogeneity in breast cancer treatment due to tissue elemental differences. Radiat Oncol. 2018. PMID: 29764450. doi:10.1186/s13014-018-1022-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。